Showing 4781-4790 of 5623 results for "".
- Glaucoma Study Findings Emphasize Need for Regular Eye Checkshttps://modernod.com/news/glaucoma-study-findings-emphasize-need-for-regular-eye-checks/2478048/People with early-stage glaucoma see the contrast of visible objects in a very similar way to people without the condition, a new study has shown. Research by the University of Bradford (UK) demonstrated that the brain compensates for the changes in the eye caused by glaucoma, when looking
- Low-Carbohydrate Diet May Be Associated With Lower Risk of Primary Open-Angle Glaucomahttps://modernod.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease-2/2478047/Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma. In a first-of-its-kind study, a researcher at New York Eye and Ear Infirmary of Mount Sinai (NYEE) helped discover that if at-risk groups a
- Norlase Announces CE Mark Approval for LEAF Green Laserhttps://modernod.com/news/norlase-announces-ce-mark-approval-for-leaf-green-laser/2478045/Norlase announced that it has been granted the CE Mark approval for the LEAF, a first in class, fiberless green laser for the treatment of retina and glaucoma diseases. The CE Mark follows the recent FDA 510(k) market clearance of the LEAF and ISO 13485:2016 certification of Norlase’s medical dev
- Oxford-AstraZeneca Covid Vaccine Study Shows Dual Immune Actionhttps://modernod.com/news/oxford-astrazeneca-covid-vaccine-study-shows-dual-immune-action/2478042/A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen, according to a Bloomberg
- Vision Expo Announces Topic for July 22 Virtual EYE2EYE Series Coffee Talkhttps://modernod.com/news/vision-expo-announces-topic-for-july-22-virtual-eye2eye-series-coffee-talk/2478039/On July 22 at 12:15 pm EDT, The Vision Council and Vision Expo will host “Open Your Eyes! What Allyship of Diversity & Inclusion Looks Like” as part of the Virtual EYE2EYE Series, a weekly series of virtual panels and interactive conversations inspired by Vision Expo’s EYE2EYE edu
- National Vision Announces Special Cash Bonus to Front-Line Associates and Doctorshttps://modernod.com/news/national-vision-announces-special-cash-bonus-to-front-line-associates-and-doctors/2478032/National Vision Holdings announced plans to grant a special cash bonus to front-line associates and doctors. A one-time $250 bonus will be given to all patient-facing and customer-facing associates and the company’s network of doctors in recognition of their hard work and dedication toward
- Topcon Acquires Henson Perimeter Businesshttps://modernod.com/news/topcon-acquires-henson-perimeter-business/2478033/Topcon Healthcare announced that it has acquired the Henson line of perimetry products, including the Henson 9000 and 7000, from Elektron Eye Technology (EET) of Cambridge, UK. Terms of the deal were not disclosed. The acquisitions include the transfer of a number of EET staff to To
- Low-Carbohydrate Diet May Be Associated With Lower Risk of Glaucomahttps://modernod.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease/2478030/Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma. In a first-of-its-kind study, a researcher at New York Eye and Ear Infirmary of Mount Sinai (NYEE) helped discover that if at-risk groups a
- AstraZeneca, IQVIA Partner to Speed Up Studies of COVID-19 Vaccine Candidatehttps://modernod.com/news/astrazeneca-iqvia-partner-to-speed-up-studies-of-covid-19-vaccine-candidate/2478022/AstraZeneca and IQVIA are teaming up to accelerate development of the UK drugmaker’s Oxford University-partnered COVID-19 vaccine candidate AZD1222, IQVIA announced Tuesday. According to the life sciences data analytics firm, the collaboration will “drive faster delivery of clin
- National Glaucoma Research Foundation Survey Reveals Patients’ Experiences and Concerns During COVID-19https://modernod.com/news/national-glaucoma-research-foundation-survey-reveals-patients-experiences-and-concerns-during-covid-19/2478017/Glaucoma Research Foundation (GRF) announced results from a survey designed to explore glaucoma patients’ experiences and concerns during the COVID-19 pandemic-related shutdowns. The survey, conducted among patients in the GRF database and suppo